Literature DB >> 35855751

Cognitive Performance is Associated with Altered Cerebral Hemodynamics Assessed by Transcranial Ultrasound in Parkinson's Disease.

Yi-Lun Ge1, Si-Yi Gong1, Pu-Zhi Wang1, Jia-Hui Yan1, Wen Li1, Jin-Ru Zhang1, Hong Jin1, Sheng Zhuang1, Lei Hu2, Chang-Wei Ding2, Ya-Ping Yang1, Fen Wang3, Dan Li4, Jing Chen1, Cheng-Jie Mao1,4, Ying-Chun Zhang2, Kai Li1, Chun-Feng Liu1,3,4.   

Abstract

Purpose: Cognitive impairment (CI) is a common but debilitating non-motor symptom in Parkinson's disease (PD). Although cerebrovascular functions are related to cognitive performance in healthy individuals, such a relation in PD remains elusive. This study aims to assess the association between cerebrovascular function and cognitive performance in PD individuals. Patients and
Methods: Two-hundred-and-one PD individuals were retrospectively included. They were subsequently divided into two groups: PD with normal cognition (PD-NC) and PD with CI (PD-CI). Cerebral hemodynamic characteristics of the middle cerebral arteries were assessed by transcranial ultrasound. The association between scores in each cognitive domain and cerebral hemodynamic parameters was further analyzed using regression analyses. Additionally, a binary logistic regression model with backward stepwise procedure was applied to build the model for discriminating CI in PD individuals. An independent dataset of additional 46 PD individuals was used further.
Results: The PD-CI group showed a relatively lower end-diastolic blood flow velocity (EDV, p < 0.05) and a higher resistive index (RI, p < 0.05) compared to the PD-NC group. RI showed significant associations with the memory item score of Montreal Cognitive Assessment (p < 0.05). A model combining clinical and hemodynamic variables was established with optimal efficiency (area under the curve, AUC = 0.651). Further replication of the model in an independent dataset yielded a great consistency (AUC = 0.704).
Conclusion: In our study, cerebrovascular functions were significantly associated with the cognitive performance in PD individuals, especially with the memory task. The established model was effective in identifying CI in PD individuals, which might be a potentially useful tool to screen the cognitive decline in PD individuals at an early stage of the disease. Further studies with larger sample sizes in different populations are warranted.
© 2022 Ge et al.

Entities:  

Keywords:  Parkinson’s disease; cognitive impairment; resistive index; transcranial ultrasound

Year:  2022        PMID: 35855751      PMCID: PMC9288215          DOI: 10.2147/NDT.S358150

Source DB:  PubMed          Journal:  Neuropsychiatr Dis Treat        ISSN: 1176-6328            Impact factor:   2.989


  48 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

3.  Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.

Authors:  Tanja Stojkovic; Elka Stefanova; Ivan Soldatovic; Vladana Markovic; Iva Stankovic; Igor Petrovic; Federica Agosta; Sebastiano Galantucci; Massimo Filippi; Vladimir Kostic
Journal:  J Neurol       Date:  2018-03-23       Impact factor: 4.849

4.  The effect of small vessel disease on motor and cognitive function in Parkinson's disease.

Authors:  Koichi Shibata; Mieko Sugiura; Yoshiko Nishimura; Hiroshi Sakura
Journal:  Clin Neurol Neurosurg       Date:  2019-05-01       Impact factor: 1.876

5.  Small-vessel disease in patients with Parkinson's disease: a clinicopathological study.

Authors:  Raymond S Schwartz; Glenda M Halliday; Dennis J Cordato; Jillian J Kril
Journal:  Mov Disord       Date:  2012-09-26       Impact factor: 10.338

6.  Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease.

Authors:  K S Wong; H Li; Y L Chan; A Ahuja; W W Lam; A Wong; R Kay
Journal:  Stroke       Date:  2000-11       Impact factor: 7.914

Review 7.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

Review 8.  Energy failure: does it contribute to neurodegeneration?

Authors:  Divya Pathak; Amandine Berthet; Ken Nakamura
Journal:  Ann Neurol       Date:  2013-10       Impact factor: 10.422

Review 9.  The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism.

Authors:  Hemant Kumar; Hyung-Woo Lim; Sandeep Vasant More; Byung-Wook Kim; Sushruta Koppula; In Su Kim; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2012-08-21       Impact factor: 6.208

Review 10.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Authors:  C H Williams-Gray; T Foltynie; C E G Brayne; T W Robbins; R A Barker
Journal:  Brain       Date:  2007-05-29       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.